← All auctions
GAD-7 change at week 8
Crossover cognitive-load study, intranasal Selank vs. placebo. PVT, GAD-7, HRV. Already awarded.
Participants
41
Ceiling
$96k
Sealed at
2025-12-08 12:00
Reveal at
2025-12-15 12:00
Sealed bids
Each bidder commits a SHA-256 hash of their offer (USD amount + turnaround days + signature). Hashes are visible immediately; values are revealed only at the auction timestamp. Until then, no party - not even the cohort host - can see any bid amount.
| Bidder | Commit hash | Amount | Turnaround | Status |
|---|---|---|---|---|
Helix CRO Netherlands (Utrecht) | $81,170 | 15 d | revealed | |
Alpine Trial Services Switzerland (Basel) | $86,723 | 137 d | Awarded | |
NorthStar Research Network Canada (Toronto) | $87,583 | 50 d | revealed | |
Atlas Clinical Research US (Boston, MA) | $90,071 | 146 d | revealed |
Auction lifecycle
01
Posting
Cohort host posts the protocol, endpoint, participant count, and budget ceiling.
02
Sealed bids
CROs commit SHA-256 of their offer + signature. Hashes go on-chain.
03
Reveal
At the timestamp, plaintext bids are revealed. The lowest compliant bid wins.
04
Escrow + delivery
Funds escrow; OEA reveal at cohort close binds the data delivery.